Alpari Futures

Regulation

Alpari (US), LLC is dually registered with the CFTC as a Futures Commission Merchant and Retail Foreign Exchange Dealer and is a member of the NFA - Member ID: 0379678.

Trading Tools

Alpari Futures supplies our investors with FREE trading technology to assist clients in making their trading decisions, technical and fundamental analysis, and other trading tools to optimize their performance.


  • Trading Central Technical Analysis is one of the leading investment research providers to financial market professionals. Alpari Futures relationship with Trading Central enables our traders to have free access to the same technical expertise that institutions, hedge funds, and investment banks implement. Please submit a request to cs@alpari-futures.com for Trading Central login info. Other investors may make their trading decisions by combining fundamental and technical analysis

 

  • Quotes & Charts are essential to monitor and trade commodities futures markets. Our clients are able to access free quotes and charts courtesy of Barchart, Inc.

 

  • Web Broadcast is an interactive bonus web feature brought to you by Trading Central


Live accounts will be provided acess with research for US futures markets with products that range from intra-day fundamental news to analysis on trading strategies. Access to high quality reports will also be available for your convenience

 

*Precious metals analysis are based off of the spot gold and spot silver market. This report is also found at www.alpari-us.com.

 

 



Alpari Futures
14 Wall Street, Suite 8B
New York, NY 10005

1-646-825-5767

cs@alpari-futures.com

Frequently Asked Questions

© 2009 - 2011 Alpari Futures

Alpari Futures is a division of Alpari (US), LLC. Alpari (US), LLC is dually registered with the CFTC as a Futures Commission Merchant and Retail Foreign Exchange Dealer and has been a member of the NFA, Member ID: 0379678, since 2007. Trading foreign exchange, commodity futures, options, precious metals and other over-the-counter products carries a high level of risk and may not be suitable for all investors.